Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler
« Previous
123456789101112
Next »

Commentary: Healthcare Reform is Ruled Constitutional

Jun 29, 2012
By: Jill Wechsler

In a 5–4 vote, the Supreme Court has ruled in favor of the Constitutionality of the Affordable Care Act.

Congress Move Promptly to Finalize FDA User Fees

Jun 20, 2012
By: Jill Wechsler

Legislation fails to establish national track-and-trace system, but tackles shortages.

Manufacturers Back Innovation Initiatives

New legislation, government programs aim to bolster drug discovery and reduce regulatory hurdles.
Jun 2, 2012
By: Jill Wechsler

New legislation, government programs aim to bolster drug discovery and reduce regulatory hurdles.

FDA Explores Options to Expand Access to Non-Rx Drugs

Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
May 2, 2012
By: Jill Wechsler

Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.

Manufacturers Wrestle with Drug Abuse and Shortages

Soaring opioid use creates challenges for new drug development and supply-chain control.
Apr 2, 2012
By: Jill Wechsler

Soaring opioid use creates challenges for new drug development and supply-chain control.

Communications Advances Present Manufacturer Challenges

Social media use raises questions about applying old standards to new information technology.
Mar 2, 2012
By: Jill Wechsler

Social media use raises questions about applying old standards to new information technology.

FDA and Justice Department Address Drug Quality Concerns

More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
Feb 2, 2012
By: Jill Wechsler

More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.

Budget Crunch, Political Battles Shape Policy Agenda for Year

Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
Jan 2, 2012
By: Jill Wechsler

Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.

FDA Revamps to Meet New Challenges

Added responsibilities and outside concerns prompt overhaul of agency's structure.
Dec 2, 2011
By: Jill Wechsler

Added responsibilities and outside concerns prompt overhaul of agency's structure.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
42%
Facility/environment problems
0%
Process development problems
8%
Production equipment downtime
8%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
17%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here